These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20704261)

  • 21. Cytotoxicity of polyspermine-ribonuclease A and polyspermine-dimeric ribonuclease A.
    Poucková P; Morbio M; Vottariello F; Laurents DV; Matousek J; Soucek J; Gotte G; Donadelli M; Costanzo C; Libonati M
    Bioconjug Chem; 2007; 18(6):1946-55. PubMed ID: 17914869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ribonuclease inhibitor as an intracellular sentry.
    Haigis MC; Kurten EL; Raines RT
    Nucleic Acids Res; 2003 Feb; 31(3):1024-32. PubMed ID: 12560499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KFERQ sequence in ribonuclease A-mediated cytotoxicity.
    Haigis MC; Kurten EL; Abel RL; Raines RT
    J Biol Chem; 2002 Mar; 277(13):11576-81. PubMed ID: 11801605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disruption of shape-complementarity markers to create cytotoxic variants of ribonuclease A.
    Rutkoski TJ; Kurten EL; Mitchell JC; Raines RT
    J Mol Biol; 2005 Nov; 354(1):41-54. PubMed ID: 16188273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiol-disulfide exchange of ribonuclease inhibitor bound to ribonuclease A. Evidence of active inhibitor-bound ribonuclease.
    Ferreras M; Gavilanes JG; López-Otín C; García-Segura JM
    J Biol Chem; 1995 Dec; 270(48):28570-8. PubMed ID: 7499372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescence assay for the binding of ribonuclease A to the ribonuclease inhibitor protein.
    Abel RL; Haigis MC; Park C; Raines RT
    Anal Biochem; 2002 Jul; 306(1):100-7. PubMed ID: 12069420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the ribonucleolytic activity of the dityrosine cross-linked Ribonuclease A dimer with its monomer in the presence of inhibitors.
    Dinda AK; Tripathy DR; Das A; Dasgupta S
    Int J Biol Macromol; 2014 Feb; 63():107-13. PubMed ID: 24184731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endowing human pancreatic ribonuclease with toxicity for cancer cells.
    Leland PA; Staniszewski KE; Kim BM; Raines RT
    J Biol Chem; 2001 Nov; 276(46):43095-102. PubMed ID: 11555655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A dimeric mutant of human pancreatic ribonuclease with selective cytotoxicity toward malignant cells.
    Piccoli R; Di Gaetano S; De Lorenzo C; Grauso M; Monaco C; Spalletti-Cernia D; Laccetti P; Cinátl J; Matousek J; D'Alessio G
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7768-73. PubMed ID: 10393896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing the potency of a cytotoxin with an arginine graft.
    Fuchs SM; Rutkoski TJ; Kung VM; Groeschl RT; Raines RT
    Protein Eng Des Sel; 2007 Oct; 20(10):505-9. PubMed ID: 17954521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure and stability of the non-covalent swapped dimer of bovine seminal ribonuclease: an enzyme tailored to evade ribonuclease protein inhibitor.
    Sica F; Di Fiore A; Merlino A; Mazzarella L
    J Biol Chem; 2004 Aug; 279(35):36753-60. PubMed ID: 15192098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the interactions of human ribonuclease inhibitor with angiogenin and ribonuclease A by mutagenesis: importance of inhibitor residues inside versus outside the C-terminal "hot spot".
    Shapiro R; Ruiz-Gutierrez M; Chen CZ
    J Mol Biol; 2000 Sep; 302(2):497-519. PubMed ID: 10970748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward an antitumor form of bovine pancreatic ribonuclease: the crystal structure of three noncovalent dimeric mutants.
    Merlino A; Russo Krauss I; Perillo M; Mattia CA; Ercole C; Picone D; Vergara A; Sica F
    Biopolymers; 2009 Dec; 91(12):1029-37. PubMed ID: 19280639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraspecies regulation of ribonucleolytic activity.
    Johnson RJ; Lavis LD; Raines RT
    Biochemistry; 2007 Nov; 46(45):13131-40. PubMed ID: 17956129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions of the cytotoxic RNase A dimers with the cytosolic ribonuclease inhibitor.
    Naddeo M; Vitagliano L; Russo A; Gotte G; D'Alessio G; Sorrentino S
    FEBS Lett; 2005 May; 579(12):2663-8. PubMed ID: 15862306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ribonucleases and their antitumor activity.
    Matousek J
    Comp Biochem Physiol C Toxicol Pharmacol; 2001 Jul; 129(3):175-91. PubMed ID: 11461835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A.
    Kobe B; Deisenhofer J
    J Mol Biol; 1996 Dec; 264(5):1028-43. PubMed ID: 9000628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor activity and other biological actions of oligomers of ribonuclease A.
    Matousek J; Gotte G; Pouckova P; Soucek J; Slavik T; Vottariello F; Libonati M
    J Biol Chem; 2003 Jun; 278(26):23817-22. PubMed ID: 12697760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the interaction of ribonuclease inhibitor with pancreatic ribonuclease involving differential labeling of cysteinyl residues.
    Hofsteenge J; Servis C; Stone SR
    J Biol Chem; 1991 Dec; 266(35):24198-204. PubMed ID: 1748689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-dimensional structure of a human pancreatic ribonuclease variant, a step forward in the design of cytotoxic ribonucleases.
    Pous J; Canals A; Terzyan SS; Guasch A; Benito A; Ribó M; Vilanova M; Coll M
    J Mol Biol; 2000 Oct; 303(1):49-60. PubMed ID: 11021969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.